Businessweek

Cross Country Healthcare, Inc. announced unaudited consolidated financial results for the first quarter ended March 31, 2013. For the quarter, the company reported revenue from services of $110,316,000 compared to $109,800,000 a year ago. Loss from operations was $199,000 compared to $914,000 a year ago. Loss from continuing operations before income taxes was $1,846,000 compared to $1,633,000 a year ago. Loss from continuing operations was $1,346,000 or $0.04 per diluted share and includes $0.03 related to the write-off of loan fees following the replacement of the prior credit facility in January, compared to income of $362,000 a year ago. Net loss was $1,158,000 or $0.04 per diluted share compared to net loss of $584,000 or $0.02 per diluted share a year ago. Adjusted EBITDA from continuing operations was $1,988,000 compared to $1,688,000 a year ago. Adjusted EBITDA was $2,467,000 compared to $3,011,000 a year ago. Net cash used by operating activities was $1,515,000 compared to provide by activities of $1,401,000 a year ago. Capital expenditures totaled approximately $200,000 in the first quarter. The company provided earnings guidance for the second quarter of 2013. For the quarter, the company expects revenue to be in the $110.0 million to $112.0 million range reflecting a mid-single-digit sequential revenue decrease in the nurse and allied staffing segment, due to market dynamics, including seasonality that Joe discussed earlier, offset by seasonal increase in the physician staffing segment. The company expects gross profit margin to be approximately 26% and adjusted EBITDA from continuing operations margin to be in the 1% to 2% range. Interest expense is expected to be approximately $200,000 in the second quarter. Income tax expense is expected to be in the $0 to $300,000 range. Based on these assumptions, the company expects loss per diluted share from continuing operations in the range of $0.01 to $0.03. For the full year of 2013, the company expects tax rate to be in the mid-60% range. The company targets capital spending of roughly $2 million.

Cross Country Healthcare, Inc. Presents at UBS Global Healthcare Conference, May-22-2013 11:00 AM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Joseph A. Boshart, Chief Executive Officer, Director and Member of Proxy Committee, William J. Grubbs, President, Chief Operating Officer and Director.

Cross Country Healthcare, Inc. announced that they will report Q1, 2013 results at 5:00 PM, Eastern Standard Time on May 07, 2013

Cross Country Healthcare, Inc., Q1 2013 Earnings Call, May 08, 2013

Cross Country Healthcare, Inc., Annual General Meeting, May 01, 2013., at 11:00 US Eastern Standard Time. Location: Proskauer Rose LLP at Eleven Times Square. Agenda: To consider election of eight directors to the company’s Board of Directors to hold office until the next annual meeting or until their respective; to consider and re-approve the code section 162(m) performance goals under the company’s 2007 stock incentive plan; to consider approval and ratification of the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2013; to consider non-binding advisory vote to approve compensation of the company’s named executive officers; and to consider and transact such other business as may properly come before the meeting or any adjournment at the meeting.